SCD1 inhibitors blocked prostate and breast cancer cell proliferation in low serum conditions, when the exogenous supply of fatty acids was limited [54,55] and these effects were rescued by addition of exogenous oleic acid. The gene discussed is SCD; the disease is breast carcinoma.